Real‐world study of treatment and outcome of type B2 + B3 thymoma: The neglected part of thymoma

This study aimed to examine the treatment and prognosis of patients with type B2 + B3 thymoma and compare it with those patients with type B2 and B3 thymoma.

[1]  Yih-Leong Chang,et al.  Clinical outcomes for patients with thymoma and thymic carcinoma after undergoing different front‐line chemotherapy regimens , 2022, Cancer medicine.

[2]  K. Jung,et al.  Trends in incidence and survival of patients with thymic epithelial tumor in a high-incidence Asian country: Analysis of the Korean Central Cancer Registry 1999-2017. , 2022, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[3]  H. Hsu,et al.  Does size affect the prognosis of resectable thymoma beyond the eighth edition TNM? , 2021, Thoracic cancer.

[4]  A. Nicholson,et al.  The 2021 World Health Organization Classification of Tumors of the Thymus and Mediastinum: What's new in thymic epithelial, germ cell and mesenchymal tumors? , 2021, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[5]  N. Girard,et al.  PECATI: A Multicentric, Open-Label, Single-Arm Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab and Lenvatinib in Pretreated B3-Thymoma and Thymic Carcinoma Patients. , 2021, Clinical lung cancer.

[6]  Q. Wei,et al.  Immune-Therapy-Related Toxicity Events and Dramatic Remission After a Single Dose of Pembrolizumab Treatment in Metastatic Thymoma: A Case Report , 2021, Frontiers in Immunology.

[7]  S. Sak,et al.  Different View on Tumor Size Dilemma in Tumor-Node-Metastasis Staging System for Thymoma , 2020, The Thoracic and Cardiovascular Surgeon.

[8]  Tomoaki Yamada,et al.  Lenvatinib in patients with advanced or metastatic thymic carcinoma (REMORA): a multicentre, phase 2 trial. , 2020, The Lancet. Oncology.

[9]  N. Girard,et al.  A Recurrence Predictive Model for Thymic Tumors and Its Implication for Postoperative Management: a Chinese Alliance for Research in Thymomas database study. , 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[10]  N. Altorki,et al.  Sensitivity and specificity of fine needle aspiration for the diagnosis of mediastinal lesions. , 2019, Annals of diagnostic pathology.

[11]  N. Girard,et al.  Systemic treatments for thymoma and thymic carcinoma: A systematic review. , 2018, Lung cancer.

[12]  N. Girard,et al.  Assessment of the ITMIG Statement on the WHO Histological Classification and of the Eighth TNM Staging of Thymic Epithelial Tumors of a Series of 188 Thymic Epithelial Tumors , 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[13]  D. Coppola,et al.  Thymoma: a clinicopathological correlation of 1470 cases. , 2017, Human pathology.

[14]  R. Camidge,et al.  The Impact of Postoperative Radiotherapy for Thymoma and Thymic Carcinoma , 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[15]  D. Planchard,et al.  Activity and safety of oral etoposide in pretreated patients with metastatic or recurrent thymic epithelial tumors (TET): A single-institution experience. , 2016, Lung cancer.

[16]  R. Toyozawa,et al.  Are Anthracycline‐Based Regimens Truly Indicated To Be the Standard Chemotherapy Regimen for Thymic Carcinoma? , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[17]  N. Girard,et al.  The 2015 World Health Organization Classification of Tumors of the Thymus: Continuity and Changes. , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[18]  H. Kim,et al.  Role of Postoperative Radiotherapy in Nonlocalized Thymoma: Propensity-Matched Analysis of Surveillance, Epidemiology, and End Results Database , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[19]  A. Nicholson,et al.  The Impact of Thymoma Histotype on Prognosis in a Worldwide Database , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[20]  Yiping Zhang,et al.  Treatment and prognosis of type B2 thymoma , 2014, World Journal of Surgical Oncology.

[21]  J. Crowley,et al.  The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: Proposal for an Evidence-Based Stage Classification System for the Forthcoming (8th) Edition of the TNM Classification of Malignant Tumors , 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[22]  A. Bezjak,et al.  Prognostic Factors for Cure, Recurrence and Long-Term Survival After Surgical Resection of Thymoma , 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[23]  N. Girard,et al.  ITMIG Consensus Statement on the Use of the WHO Histological Classification of Thymoma and Thymic Carcinoma: Refined Definitions, Histological Criteria, and Reporting , 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[24]  F. Detterbeck,et al.  [Standard outcome measures for thymic malignancies]. , 2014, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

[25]  G. Giaccone,et al.  Cixutumumab for patients with recurrent or refractory advanced thymic epithelial tumours: a multicentre, open-label, phase 2 trial. , 2014, The Lancet. Oncology.

[26]  W. Fang,et al.  Outcome of Multimodality Treatment for 188 Cases of Type B3 Thymoma , 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[27]  Shun Lu,et al.  Long‐term survival in thymic epithelial tumors: A single‐center experience from China , 2013, Journal of surgical oncology.

[28]  Y. Shim,et al.  Type B thymoma: is prognosis predicted only by World Health Organization classification? , 2010, The Journal of thoracic and cardiovascular surgery.

[29]  H. Müller-Hermelink,et al.  Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: a retrospective analysis. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  H. Asamura,et al.  A review of 79 thymomas: Modification of staging system and reappraisal of conventional division into invasive and non‐invasive thymoma , 1994, Pathology international.